Friday, March 31, 2023
WebMD Global requires each individual who is in a position to control the content of one of its educational activities to disclose any relevant financial relationships occurring within the past 12 months that could create a conflict of interest.
All of the relevant financial relationships listed for these individuals have been mitigated.
Professor of Genitourinary Oncology
Barts Cancer Institute
Queen Mary University of London
London, United Kingdom
Department of Cancer Medicine
Université Paris-Saclay
Institut Gustave Roussy
Villejuif, France
Medical Oncologist
Chief, Genitourinary Medical Oncology Service
Division of Solid Tumor Oncology
Enno W. Ercklentz Chair
Memorial Sloan Kettering Cancer Center
New York, New York, United States
This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.
This educational activity is intended for an international audience of non-US hematology and oncology specialists, urologists and pathologists.
The goal of this activity is to increase physician knowledge of the rationale and available evidence for emerging targeted therapies as well as their implications for the management of patients with advanced/metastatic urothelial carcinoma.
Upon completion of this activity, participants will:
WebMD Global requires each individual who is in a position to control the content of one of its educational activities to disclose any relevant financial relationships occurring within the past 12 months that could create a conflict of interest.
All of the relevant financial relationships listed for these individuals have been mitigated.
Professor of Genitourinary Oncology
Barts Cancer Institute
Queen Mary University of London
London, United Kingdom
Department of Cancer Medicine
Université Paris-Saclay
Institut Gustave Roussy
Villejuif, France
Medical Oncologist
Chief, Genitourinary Medical Oncology Service
Division of Solid Tumor Oncology
Enno W. Ercklentz Chair
Memorial Sloan Kettering Cancer Center
New York, New York, United States
This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.
The Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom (FPM) has reviewed and approved the content of this educational activity and allocated it 0.5 continuing professional development credits (CPD).
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information about your
eligibility to claim credit, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent participating in the activity. To successfully earn credit, participants must
complete the activity online during the credit eligibility period that is noted on the title page.
Follow these steps to claim a credit certificate for completing this activity:
We encourage you to complete an Activity Evaluation to provide feedback for future programming.
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print
out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.
*The credit that you receive is based on your user profile.
CPD Released: 12/10/2021
Valid for credit through: 12/10/2022
processing....
A Powerpoint version of the slides from this presentation
is available for use as a professional resource from Medscape Education.
